Robert Lyne
Net worth: 275 574 $ as of 2026-06-29
Net worth: 275 574 $ as of 2026-06-29
Robert William Henry Lyne is currently Chief Executive Officer & Director at PureTech Health Plc starting in 2025.
He is CEO and General Counsel at Arix Bioscience since 2021.
He serves as Director at Arix Bioscience Holdings Ltd. since 2017, Director at Seaport Therapeutics, Inc., and Board Member at Arix Capital Management Ltd. Formerly, Mr. Lyne was Chief Executive Officer at Arix Bioscience Plc from 2021 to 2023 and worked as an Associate at Bird & Bird LLP.
Education includes undergraduate studies at the University of Oxford and graduate studies at Oxford Brookes University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PURETECH HEALTH PLC 0.06% | 2026-07-07 | 151,112 ( 0.06% ) | 275 574 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| PURETECH HEALTH PLC | Chief Executive Officer | 2025-07-14 |
Arix Capital Management Ltd.
Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, diagnostics, medical technology, biotech, pharmaceuticals and life science services. It provides financing for early & later stage capital requirements with an investment size of GBP 0.5 - 5 million and also makes follow-on investments. | Director/Board Member | - |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Chief Executive Officer | 2021-09-30 |
Arix Bioscience Holdings Ltd.
Arix Bioscience Holdings Ltd. Medical/Nursing ServicesHealth Services Provides support services to healthcare and lift science business | Director/Board Member | 2017-12-05 |
| Companies | Position | End |
|---|---|---|
| ARIX BIOSCIENCE PLC | Chief Executive Officer | 2023-11-30 |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arix Capital Management Ltd.
Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, diagnostics, medical technology, biotech, pharmaceuticals and life science services. It provides financing for early & later stage capital requirements with an investment size of GBP 0.5 - 5 million and also makes follow-on investments. | Finance |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Arix Bioscience Plc
Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Arix Bioscience Holdings Ltd.
Arix Bioscience Holdings Ltd. Medical/Nursing ServicesHealth Services Provides support services to healthcare and lift science business | Health Services |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions